These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30842496)

  • 21. Ripasudil hydrochloride hydrate: targeting Rho kinase in the treatment of glaucoma.
    Inoue T; Tanihara H
    Expert Opin Pharmacother; 2017 Oct; 18(15):1669-1673. PubMed ID: 28893104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraocular pressure-lowering effects of ripasudil in uveitic glaucoma, exfoliation glaucoma, and steroid-induced glaucoma patients: ROCK-S, a multicentre historical cohort study.
    Futakuchi A; Morimoto T; Ikeda Y; Tanihara H; Inoue T;
    Sci Rep; 2020 Jun; 10(1):10308. PubMed ID: 32587304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness and safety of switching from prostaglandin analog monotherapy to prostaglandin/timolol fixed combination therapy or adding ripasudil.
    Inoue K; Ishida K; Tomita G
    Jpn J Ophthalmol; 2018 Jul; 62(4):508-516. PubMed ID: 29797109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term Side Effects Including Blepharitis Leading to Discontinuation of Ripasudil.
    Saito H; Kagami S; Mishima K; Mataki N; Fukushima A; Araie M
    J Glaucoma; 2019 Apr; 28(4):289-293. PubMed ID: 30720574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An update on ripasudil for the treatment of glaucoma and ocular hypertension.
    Testa V; Ferro Desideri L; Della Giustina P; Traverso CE; Iester M
    Drugs Today (Barc); 2020 Sep; 56(9):599-608. PubMed ID: 33025953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of ripasudil after trabeculectomy with mitomycin C: a multicentre, randomised, prospective clinical study.
    Muhlisah A; Hirooka K; Nurtania A; Onoe H; Okumichi H; Nitta E; Baba T; Tanito M; Matsuoka Y; Nakakura S; Kiuchi Y
    BMJ Open Ophthalmol; 2024 Jul; 9(1):. PubMed ID: 38960415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ripasudil hydrochloride hydrate (K-115), a Rho-kinase inhibitor, on ocular blood flow and ciliary artery smooth muscle contraction in rabbits.
    Ohta Y; Takaseki S; Yoshitomi T
    Jpn J Ophthalmol; 2017 Sep; 61(5):423-432. PubMed ID: 28653193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension.
    Tanna AP; Johnson M
    Ophthalmology; 2018 Nov; 125(11):1741-1756. PubMed ID: 30007591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation.
    Maruyama Y; Ikeda Y; Mori K; Yoshii K; Ueno M; Yoshikawa H; Sotozono C; Kinoshita S
    Br J Ophthalmol; 2021 Feb; 105(2):169-173. PubMed ID: 32269062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant.
    Lazic R; Lukic M; Boras I; Draca N; Vlasic M; Gabric N; Tomic Z
    Retina; 2014 Apr; 34(4):719-24. PubMed ID: 23975006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting.
    Vo Kim S; Fajnkuchen F; Sarda V; Qu-Knafo L; Bodaghi B; Giocanti-Aurégan A
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2165-2171. PubMed ID: 28831613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
    Shimura M; Nakazawa T; Yasuda K; Shiono T; Iida T; Sakamoto T; Nishida K
    Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma.
    Honjo M; Tanihara H
    Jpn J Ophthalmol; 2018 Mar; 62(2):109-126. PubMed ID: 29445943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for ocular hypertension after intravitreal dexamethasone implantation in diabetic macular edema.
    Choi MY; Kwon JW
    Sci Rep; 2020 Aug; 10(1):13736. PubMed ID: 32792579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension.
    Yasuda M; Takayama K; Kanda T; Taguchi M; Someya H; Takeuchi M
    PLoS One; 2017; 12(10):e0185305. PubMed ID: 28968412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocular hypotensive effect of the Rho kinase inhibitor AR-12286 in patients with glaucoma and ocular hypertension.
    Williams RD; Novack GD; van Haarlem T; Kopczynski C;
    Am J Ophthalmol; 2011 Nov; 152(5):834-41.e1. PubMed ID: 21794845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS.
    Reid GA; Sahota DS; Sarhan M
    Retina; 2015 Aug; 35(8):1647-55. PubMed ID: 25932545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Ripasudil as a Second-line Medication in Addition to a Prostaglandin Analog in Patients with Exfoliation Glaucoma: A Pilot Study.
    Matsumura R; Inoue T; Matsumura A; Tanihara H
    Clin Drug Investig; 2017 Jun; 37(6):535-539. PubMed ID: 28349329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twice-daily brinzolamide/brimonidine fixed combination versus brinzolamide or brimonidine in open-angle glaucoma or ocular hypertension.
    Aung T; Laganovska G; Hernandez Paredes TJ; Branch JD; Tsorbatzoglou A; Goldberg I
    Ophthalmology; 2014 Dec; 121(12):2348-55. PubMed ID: 25064721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety, efficacy, and patient selection of ripasudil in patients with uncontrolled glaucoma with maximum conventional medical therapy.
    Jethva J; Bhagat P; Prajapati K; Tank G
    Indian J Ophthalmol; 2022 Jun; 70(6):2020-2023. PubMed ID: 35647972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.